PROCEPT BioRobotics Corp. (PRCT)
21.24
-0.44
(-2.03%)
USD |
NASDAQ |
Aug 24, 16:00
21.24
0.00 (0.00%)
After-Hours: 20:00
PROCEPT BioRobotics Enterprise Value : 1.091B for Aug. 21, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 1.091B |
| August 20, 2026 | 1.036B |
| August 19, 2026 | 1.104B |
| August 18, 2026 | 1.070B |
| August 17, 2026 | 1.057B |
| August 14, 2026 | 1.089B |
| August 13, 2026 | 1.106B |
| August 12, 2026 | 1.066B |
| August 11, 2026 | 1.160B |
| August 10, 2026 | 1.092B |
| August 07, 2026 | 1.018B |
| August 06, 2026 | 996.24M |
| August 05, 2026 | 956.74M |
| August 04, 2026 | 896.06M |
| August 03, 2026 | 901.79M |
| July 31, 2026 | 915.53M |
| July 30, 2026 | 880.03M |
| July 29, 2026 | 873.16M |
| July 28, 2026 | 884.61M |
| July 27, 2026 | 862.29M |
| July 24, 2026 | 805.04M |
| July 23, 2026 | 854.27M |
| July 22, 2026 | 862.86M |
| July 21, 2026 | 909.80M |
| July 20, 2026 | 949.87M |
| Date | Value |
|---|---|
| July 17, 2026 | 949.87M |
| July 16, 2026 | 948.73M |
| July 15, 2026 | 945.87M |
| July 14, 2026 | 955.03M |
| July 13, 2026 | 1.064B |
| July 10, 2026 | 1.045B |
| July 09, 2026 | 980.21M |
| July 08, 2026 | 982.79M |
| July 07, 2026 | 1.053B |
| July 06, 2026 | 1.064B |
| July 02, 2026 | 1.053B |
| July 01, 2026 | 1.193B |
| June 30, 2026 | 1.142B |
| June 29, 2026 | 1.117B |
| June 26, 2026 | 1.116B |
| June 25, 2026 | 1.055B |
| June 24, 2026 | 1.019B |
| June 23, 2026 | 1.004B |
| June 22, 2026 | 1.031B |
| June 18, 2026 | 1.068B |
| June 17, 2026 | 1.022B |
| June 16, 2026 | 1.090B |
| June 15, 2026 | 1.154B |
| June 12, 2026 | 1.295B |
| June 11, 2026 | 1.408B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Insulet Corp. | 10.69B |
| Globus Medical, Inc. | 11.18B |
| Abbott Laboratories | 229.49B |
| Alphatec Holdings, Inc. | 1.956B |
| Artivion, Inc. | 1.698B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -26.86M |
| Revenue (Quarterly) | 94.50M |
| Total Expenses (Quarterly) | 121.36M |
| EPS Diluted (Quarterly) | -0.4707 |
| Gross Profit Margin (Quarterly) | 66.01% |
| Profit Margin (Quarterly) | -28.42% |
| Earnings Yield | -9.17% |
| Normalized Earnings Yield | -9.167 |